Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01340079 · ClinicalTrials.gov registry record · Phase 1

Virtual World Health Behavior Counseling for Patients With Diabetes

A Phase 1 study, sponsored by Boston Medical Center.

Completed
Registry status
Phase 1
Development phase
89
Enrollment target

NCT01340079: Completed Phase 1 study, sponsored by Boston Medical Center.

NCT01340079 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 89 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01340079, a Phase 1 study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
89 participants
Enrollment target

Study Summary

Comparison of 2 methods of delivery health education for African-American women with Type 2 Diabetes. The two methods are: face to face education in small groups, as compared to delivering the same curriculum in the virtual world, Second Life.

Interventions

  • BEHAVIORAL virtual world
  • BEHAVIORAL face to face

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2011-04
Est. Completion 2012-07
Phase Phase 1
Boston Medical Center

253 total trials

What the finished NCT01340079 record still lists

NCT01340079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% higher).

The record links to 0 conditions, and to 2 interventions - of which virtual world is the first listed.

NCT01340079 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01340079 about?

NCT01340079 is a clinical study titled "Virtual World Health Behavior Counseling for Patients With Diabetes". Comparison of 2 methods of delivery health education for African-American women with Type 2 Diabetes. The two methods are: face to face education in small groups, as compared to delivering the same curriculum in the virtual world, Second Life.

What is the current status of trial NCT01340079?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 89 participants. The study started on 2011-04. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01340079?

The interventions under investigation include: virtual world (BEHAVIORAL), face to face (BEHAVIORAL).

Who is sponsoring clinical trial NCT01340079?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01340079's enrollment target sits among peer trials

89 649th of 2000 higher than 1,351 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01340079, the US trial registry maintained by the National Library of Medicine. NCT01340079 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.